Buyers Say Teva Had Multipart Scheme To Delay Inhaler Rivals
By Matthew Perlman · July 10, 2024, 6:35 PM EDT
Employee benefit funds accusing Teva of orchestrating a decadelong scheme to delay generic competition for its QVAR asthma inhalers told a Massachusetts federal court the drugmaker is trying to end the...
To view the full article, register now.